Wells Fargo Starts Abbvie (ABBV) at Outperform

January 16, 2013 8:15 AM EST Send to a Friend
Wells Fargo initiates coverage on Abbvie (NYSE: ABBV) with a Outperform rating and $37-$40 valuation range.

The firm is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login